%0 Journal Article
%B Diabetes, Obesity and Metabolism
%D 2019
%P 1237 - 1250
%T Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysis
%V 21